Cargando…

Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer

PURPOSE: Targeted therapy is the cornerstone of treatment of advanced EGFR-mutant non–small-cell lung cancer (NSCLC). Next-generation sequencing (NGS), the preferred method for genotyping, typically requires several weeks. Here, we assessed workflows designed to rapidly identify patients with action...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagogo-Jack, Ibiayi, Azzolli, Christopher G., Fintelmann, Florian, Mino-Kenudson, Mari, Farago, Anna F., Gainor, Justin F., Jiang, Ginger, Piotrowska, Zofia, Heist, Rebecca S., Lennes, Inga T., Temel, Jennifer S., Mooradian, Meghan J., Lin, Jessica J., Digumarthy, Subba R., Batten, Julie M., Robinson, Hayley, Nose, Vania, Rivera, Miguel, Nardi, Valentina, Dias-Santagata, Dora, Le, Long P., Sequist, Lecia V., Pitman, Martha, Shepard, Jo-Anne O., Shaw, Alice T., Iafrate, A. John, Lennerz, Jochen K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2018
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200882/ https://www.ncbi.nlm.nih.gov/pubmed/30370396 http://dx.doi.org/10.1200/PO.17.00299

Ejemplares similares

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC
por: Cooper, Alissa J., et al.
Publicado: (2022)

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Coronavirus Disease 2019 Infection in a Patient Population with Lung Cancer: Incidence, Presentation, and Alternative Diagnostic Considerations
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2020)

Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?
por: Digumarthy, Subba R., et al.
Publicado: (2019)

Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
por: Digumarthy, Subba R., et al.
Publicado: (2019)

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution
por: Schneider, Jaime L., et al.
Publicado: (2023)

Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer
por: Fintelmann, Florian J., et al.
Publicado: (2019)

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
por: Digumarthy, Subba R., et al.
Publicado: (2019)

B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
por: Digumarthy, Subba R., et al.
Publicado: (2019)

Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation
por: Wu, Markus Y., et al.
Publicado: (2021)

Role of imaging biomarkers in mutation-driven non-small cell lung cancer
por: Mendoza, Dexter P, et al.
Publicado: (2020)

Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer
por: Padole, Atul, et al.
Publicado: (2020)

A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib
por: Schneider, Jaime L., et al.
Publicado: (2022)

Determining malignancy in CT guided fine needle aspirate biopsy of subsolid lung nodules: Is core biopsy necessary?
por: Kiranantawat, Nantaka, et al.
Publicado: (2019)

Incidence of Radiation Therapy Among Patients Enrolled in a Multidisciplinary Pulmonary Nodule and Lung Cancer Screening Clinic
por: Milligan, Michael G., et al.
Publicado: (2022)

Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study
por: Lin, J.J., et al.
Publicado: (2021)

Phase II Study of Cabozantinib in Patients With Bone Metastasis
por: Choy, Edwin, et al.
Publicado: (2022)

Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
por: Lin, Jessica J., et al.
Publicado: (2020)

Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2016)

The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2020)

Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care
por: Kodack, David P., et al.
Publicado: (2017)

Role of sex in lung cancer risk prediction based on single low-dose chest computed tomography
por: Simon, Judit, et al.
Publicado: (2023)

ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack
por: Mooradian, Meghan J., et al.
Publicado: (2017)

Management of Lung Cancer in the Patient with Interstitial Lung Disease
por: Frank, Angela J, et al.
Publicado: (2022)

Clinical role, safety and diagnostic accuracy of percutaneous transthoracic needle biopsy in the evaluation of pulmonary consolidation
por: Kiranantawat, Nantaka, et al.
Publicado: (2019)

Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2019)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

Is Weight-Based Adjustment of Automatic Exposure Control Necessary for the Reduction of Chest CT Radiation Dose?
por: Prakash, Priyanka, et al.
Publicado: (2010)

Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
por: Mino-Kenudson, Mari
Publicado: (2016)

Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective
por: Mino-Kenudson, Mari
Publicado: (2020)

Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with RET Rearrangements
por: Digumarthy, Subba R., et al.
Publicado: (2020)

Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms
por: Ono, Jill, et al.
Publicado: (2011)

CT texture analysis of histologically proven benign and malignant lung lesions
por: Digumarthy, Subba R., et al.
Publicado: (2018)

Process improvement for reducing side discrepancies in radiology reports
por: Digumarthy, Subba Rao, et al.
Publicado: (2018)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
por: Dias-Santagata, Dora, et al.
Publicado: (2011)

Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer
por: Burr, Risa, et al.
Publicado: (2023)

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
por: Gainor, J. F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o55tgql03j050a66238b5ecq1g